The Vanguard Group Discloses Position in Spire Healthcare Group

The Vanguard Group, Inc. has submitted a Form 8.3 disclosure, detailing its stake in Spire Healthcare Group plc. The document, dated August 10, 2026, reveals that The Vanguard Group holds 14,293,640 ordinary shares, representing a 3.55% interest in Spire Healthcare. The disclosure pertains to positions in relevant securities according to Rule 8.3 of the Takeover Code.

The document also records a purchase of 5,375 ordinary shares at a rate of 2.34 GBP per unit. As of the disclosure date, no additional positions in cash-settled or stock-settled derivatives were reported. The Vanguard Group maintains transparency by stating there are no indemnity or option arrangements influencing transaction decisions.

At this time, no supplemental open position information has been attached to the form, as confirmed by the absence of additional agreement disclosures.